EV/EBITDA
-0.96
+0.06+5.88%
Wed, 27 Nov 2024 21:17:23 GMT
Summary:
Cartesian Therapeutics EV/EBITDA is currently -0.96, with a rise of +0.06 (+5.88%) during the most recent trading day. Over the past year, it has increased by +2.83 (+74.67%). RNAC EV/EBITDA is now -116.96% below its all-time high of 5.66.RNAC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +5.9% |
| 1 m1 month | +11.9% |
| 3 m3 months | -2.1% |
| 6 m6 months | +24.4% |
| ytdytd | -405.3% |
| 1 y1 year | +74.7% |
| 5 y5 years | +20.7% |
RNAC EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.83 | -15.7% | -1.30 | +26.1% |
| 3 m | 3 months | -0.29 | -231.0% | -1.47 | +34.7% |
| 6 m | 6 months | -0.29 | -231.0% | -2.12 | +54.7% |
| 1 y | 1 year | 0.07 | -1471.4% | -4.67 | +79.4% |
| 3 y | 3 years | 5.66 | -117.0% | -60.03 | +98.4% |
| 5 y | 5 years | 5.66 | -117.0% | -60.03 | +98.4% |
| alltime | all time | 5.66 | -117.0% | -60.03 | +98.4% |
Cartesian Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.96(+405.3%) |
| 2023 | -0.19(-107.1%) |
| 2022 | 2.67(-104.6%) |
| 2021 | -57.64(+1610.4%) |
| Date | Value |
|---|---|
| 2020 | -3.37(+32.7%) |
| 2019 | -2.54(+262.9%) |
| 2018 | -0.70(-73.9%) |
| 2017 | -2.68(-66.0%) |
| 2016 | -7.89 |
FAQ
- What is Cartesian Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Cartesian Therapeutics?
- What is RNAC EV/EBITDA year-to-date change?
- What is Cartesian Therapeutics EV/EBITDA year-on-year change?
What is Cartesian Therapeutics EV/EBITDA?
The current EV/EBITDA of RNAC is -0.96
What is the all time high EV/EBITDA for Cartesian Therapeutics?
Cartesian Therapeutics all-time high EV/EBITDA is 5.66
What is RNAC EV/EBITDA year-to-date change?
Cartesian Therapeutics EV/EBITDA has changed by -0.77 (-405.26%) since the beginning of the year
What is Cartesian Therapeutics EV/EBITDA year-on-year change?
Over the past year, RNAC EV/EBITDA has changed by +2.83 (+74.67%)